USB
46
4
AVB
72
3
WHR
70
-2
CVS
44
-5
MET
60
-3
UA
47
-4
SLB
56
4
SIG
55
3
CA
36
4
ABBV
64
-4
AMG
38
-5
PEP
63
22
AON
45
6
CF
42
-3
AMT
64
2
GRMN
64
2
MRK
50
-3
ETR
49
2
SO
66
-4
CCI
36
3
USB
46
4
AVB
72
3
WHR
70
-2
CVS
44
-5
MET
60
-3
UA
47
-4
SLB
56
4
SIG
55
3
CA
36
4
ABBV
64
-4
AMG
38
-5
PEP
63
22
AON
45
6
CF
42
-3
AMT
64
2
GRMN
64
2
MRK
50
-3
ETR
49
2
SO
66
-4
CCI
36
3
Financhill
Back

Credit Acceptance Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
49

CACC
Credit Acceptance

Last Price:
514.68
Seasonality Move:
7.75%
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
41.06
Seasonality Move:
-0.9%
Sell
49
Credit Acceptance (CACC) is a Sell

Is Credit Acceptance a Buy, Sell or Hold?

  • The current Credit Acceptance [CACC] share price is $495.92. The Score for CACC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CACC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CACC Stock Price Chart

What is Credit Acceptance's stock price today?

  • The Credit Acceptance share price today is $495.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CACC is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CACC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.02 Sell
Relative Strength Index (14 RSI): 54.01 Buy
Chaikin Money Flow: -29077 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (477.05 - 491.23) Buy
Bollinger Bands (100): (496.32 - 556.02) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

CACC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 489.13 Buy
20-day SMA: 484.81 Buy
50-day SMA: 500.14 Sell
200-day SMA: 500.7 Sell
8-day EMA: 489.92 Buy
20-day EMA: 488.42 Buy
50-day EMA: 499.87 Sell
200-day EMA: 506.39 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

Credit Acceptance Earnings Growth & CACC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, an increase next quarter of $0.91 per share, a decrease this year of $3.98 per share, and an increase next year of $7.35 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Credit Acceptance Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):